全文获取类型
收费全文 | 83229篇 |
免费 | 1945篇 |
国内免费 | 45篇 |
专业分类
85219篇 |
出版年
2018年 | 902篇 |
2017年 | 1077篇 |
2016年 | 2800篇 |
2015年 | 6166篇 |
2014年 | 5739篇 |
2013年 | 5512篇 |
2012年 | 4696篇 |
2011年 | 1928篇 |
2010年 | 2051篇 |
2009年 | 1999篇 |
2008年 | 513篇 |
2007年 | 470篇 |
2006年 | 512篇 |
2005年 | 6618篇 |
2004年 | 5314篇 |
2003年 | 3510篇 |
2002年 | 1065篇 |
2001年 | 1074篇 |
2000年 | 308篇 |
1999年 | 1458篇 |
1998年 | 322篇 |
1997年 | 164篇 |
1992年 | 1921篇 |
1991年 | 2008篇 |
1990年 | 2069篇 |
1989年 | 1997篇 |
1988年 | 1952篇 |
1987年 | 1811篇 |
1986年 | 1623篇 |
1985年 | 1651篇 |
1984年 | 1086篇 |
1983年 | 833篇 |
1982年 | 457篇 |
1981年 | 420篇 |
1980年 | 368篇 |
1979年 | 1073篇 |
1978年 | 762篇 |
1977年 | 607篇 |
1976年 | 630篇 |
1975年 | 872篇 |
1974年 | 994篇 |
1973年 | 1006篇 |
1972年 | 953篇 |
1971年 | 928篇 |
1970年 | 820篇 |
1969年 | 830篇 |
1968年 | 734篇 |
1967年 | 751篇 |
1966年 | 584篇 |
1965年 | 431篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
161.
Amira Alkharusi Elena Lesma Silvia Ancona Eloisa Chiaramonte Thomas Nystr?m Alfredo Gorio Gunnar Norstedt 《PloS one》2016,11(1)
Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease caused by mutations in the tumor suppressor genes encoding Tuberous Sclerosis Complex (TSC) 1 and TSC2. The protein product of the TSC2 gene is a well-known suppressor of the mTOR pathway. Emerging evidence suggests that the pituitary hormone prolactin (Prl) has both endocrine and paracrine modes of action. Here, we have investigated components of the Prl system in models for LAM. In a TSC2 (+/-) mouse sarcoma cell line, down-regulation of TSC2 using siRNA resulted in increased levels of the Prl receptor. In human LAM cells, the Prl receptor is detectable by immunohistochemistry, and the expression of Prl in these cells stimulates STAT3 and Erk phosphorylation, as well as proliferation. A high affinity Prl receptor antagonist consisting of Prl with four amino acid substitutions reduced phosphorylation of STAT3 and Erk. Antagonist treatment further reduced the proliferative and invasive properties of LAM cells. In histological sections from LAM patients, Prl receptor immuno reactivity was observed. We conclude that the Prl receptor is expressed in LAM, and that loss of TSC2 increases Prl receptor levels. It is proposed that Prl exerts growth-stimulatory effects on LAM cells, and that antagonizing the Prl receptor can block such effects. 相似文献
162.
Fátima H. Vaz Patrícia M. Machado Rita D. Brand?o Cátia T. Laranjeira Joana S. Eugénio Aires H. Fernandes Saudade P. André 《The journal of histochemistry and cytochemistry》2007,55(11):1105-1113
Only 20-25% of families screened for BRCA1/2 mutations are found positive. Because only a positive result is informative, we studied the role of BRCA1/2 immunohistochemistry as an additional method for patient selection. From 53 high-risk-affected probands, 18 (34%) had available paraffin blocks of their tumors and were selected for this study. Mutation screening was done by conformation-sensitive gel electrophoresis and multiplex ligation-dependent probe amplification. For immunohistochemistry, 21 neoplastic specimens (15 breast carcinomas, 5 ovary neoplasms, and 1 rectal adenocarcinoma) were analyzed with BRCA1 (monoclonal antibody, Ab-1, oncogene) and BRCA2 (polyclonal antibody, Ab-2, oncogene) antibodies. Absence of the BRCA1 protein was confirmed in negative tumors by Western blotting. Seven patients were positive for BRCA1/2 mutations: 5 for BRCA1 and 2 for BRCA2. Four out of five positive patients had tumors negative for BRCA1 immunostaining, and the remaining 13 BRCA1-negative patients had positive BRCA1 immunostaining in all tumor samples. Sensitivity to predict for BRCA1 mutation carriers was 80%, and specificity was 100%, with a positive predictive value of 100% and a negative predictive value of 93%. This correlation was statistically significant (p=0.001). No correlation was observed for BRCA2. If larger studies confirm these results, high-risk patients with BRCA1-negative tumors should be screened first for this gene. 相似文献
163.
164.
Our studies aimed at determining a loss of active heparin from the peritoneal cavity after its intraperitoneal administration (250 JU/l of dialysis fluid) in 16 patients treated because of the end-stage renal failure with intermittent peritoneal dialysis and at comparing heparin influx clearance with that of glucose. It has been shown that heparin used in this dose loses 60-70% of its activity after 20-minute equilibration of dialysis fluid in the peritoneal cavity. Heparin influx clearance is higher than that of glucose but it depends on utilization of heparin in peritoneal cavity rather than on its penetration to the blood circulation. 相似文献
165.
166.
167.
168.
169.
170.
The anatomical basis for the application of neurovascular pedicled muscle transfers of the digastric and stylohyoid muscles in the treatment of velopharynx incompetence is described. The fact that the neurovascular pedicle is located in the cranial third of the muscle bellies provides the safety of the operative procedure. The muscles have to be dissected with respect to that. The direction in which the transferred muscles pull is described. The muscle transposition is combined with the classic Wardill-Kilner operation to lengthen the soft palate. The transferred muscles have to avoid scar contraction and shortening of the soft palate and to gain a muscular function of the soft palate. The clinical use is justified in rare cases as demonstrated in one case. 相似文献